Max Reinhardt
2019
In 2019, Max Reinhardt earned a total compensation of $4.6M as President at Pacira Pharmaceuticals.
Compensation breakdown
| Bonus | $140,000 |
|---|---|
| Option Awards | $4,145,775 |
| Salary | $266,000 |
| Other | $23,263 |
| Total | $4,575,038 |
Reinhardt received $4.1M in option awards, accounting for 91% of the total pay in 2019.
Reinhardt also received $140K in bonus, $266K in salary and $23.3K in other compensation.
Rankings
In 2019, Max Reinhardt's compensation ranked 2,488th out of 13,971 executives tracked by ExecPay. In other words, Reinhardt earned more than 82.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,488 out of 13,971 | 82nd |
Division Manufacturing | 897 out of 5,695 | 84th |
Major group Chemicals And Allied Products | 291 out of 2,194 | 87th |
Industry group Drugs | 235 out of 1,880 | 88th |
Industry Pharmaceutical Preparations | 172 out of 1,392 | 88th |
Pay ratio
| Max Reinhardt's Pay | $4,575,038 |
|---|---|
| Median Employee's Pay | $155,462 |
| Pay Ratio | 29to 1 |
In 2019, the annual total compensation of Max Reinhardt was $4,575,038.
The annual total compensation of the median employee at Pacira Pharmaceuticals was $155,462.
The ratio of Max Reinhardt's pay to the pay of median employee was therefore 29 to one.
Source: SEC filing on April 24, 2020.
Reinhardt's colleagues
We found four more compensation records of executives who worked with Max Reinhardt at Pacira Pharmaceuticals in 2019.